The American Hospital Association (AHA) today announced it has exclusively endorsed Vestagen Technical Textiles, Inc.’s Vestex® Active Barrier Apparel, a protective fabric that combines fluid repellency and antimicrobial technologies embedded into health care worker scrubs, lab coats and jackets. AHA Solutions, Inc., a subsidiary of the AHA, awards the AHA Endorsement to products and services that help member hospitals and health care organizations achieve operational excellence.
Read More →
Trice Medical™, a private medical device company focused on micro invasive technologies, today announced that it closed its Series B financing totaling $18.1 million.
Read MoreTrice Medical, which has developed technology that allows doctors to diagnose orthopedic injuries in their office, has raised an additional $6.5 million in a private equity financing.
The King of Prussia, Pa., medical device company has now raised a total of $18 million through the series B financing, which was led by Safeguard Scientifics Inc. (NYSE: SFE) of Wayne, Pa.
Read More →
Gene expression profiling with a commercially available test (DecisionDx-Melanoma, Castle Biosciences) provides useful prognostic information for patients with high-risk cutaneous melanoma who undergo sentinel lymph node (SLN) biopsy, and particularly for those found to be node-negative, according to a study presented at the annual meeting of the American Society for Clinical Oncology.
Read More →
Castle Biosciences, Inc., a cancer-focused molecular diagnostics company, today announced the completion of an $11.8 million financing. The round was led by new investor HealthQuest Capital, with participation by Castle Biosciences’ current investors including Mountain Group Capital and Affiliates, Longfellow Venture Partners and others. In conjunction with this financing, Garheng Kong, M.D., Ph.D., Managing Partner of HealthQuest Capital, will join Castle Biosciences’ Board of Directors.
Read More →
First Aid Shot Therapy, makers of First Aid Shot Therapy Pain Relief, today announced the launch of its newest offering, First Aid Shot Therapy Upset Stomach. Upset Stomach is the second variant to be launched in the F.A.S.T. range of products and it is formulated to relive upset stomach symptoms. It comes in a great-tasting, smooth, ready-to-drink, liquid shot form, which starts to work immediately.
Read More →
First Aid Shot Therapy, makers of First Aid Shot Therapy Pain Relief, today announced the launch of its newest offering, First Aid Shot Therapy Upset Stomach. Upset Stomach is the second variant to be launched in the F.A.S.T. range of products and it is formulated to relive upset stomach symptoms. It comes in a great-tasting, smooth, ready-to-drink, liquid shot form, which starts to work immediately.
Read More →
First Aid Shot Therapy® (F.A.S.T.), a consumer healthcare company focused on over-the-counter (OTC) medicine in liquid ‘shot’ form, announced today that it has completed a Series B financing round.
Read MoreVestagen Technical Textiles, Inc., today announced that it has obtained worldwide rights from Schoeller Technologies AG to certain technologies that are integral to the unique properties of Vestex, the first of its families of active barrier protective fabrics that are clinically proven to prevent or reduce the acquisition and retention of microbes and other contaminants.
Read More →
HealthQuest joined Advent Ventures and Clearwell group in the extension to provide additional working capital to advanced healthcare textiles company Vestagen, based in Orlando FL. The additional funds will support expanded commercialization of Vestex®, the first in a new class of active barrier protective fabrics for everyday use that are clinically proven to prevent or reduce the acquisition and retention of microbes and other contaminants.
Read More →
